CLINICAL_TRIALS
trial_result
· 2025-04-09
Clinical Trial Update: A Study of Imlifidase in Patients With Guillain-Barré Syndrome [Phase 2]
Summary
This clinical trial update reports results from a Phase 2 study of imlifidase in Guillain-Barré syndrome. The trial is completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hansa Biopharma AB | Conditions: Guillain-Barré Syndrome (GBS) | Phase 2 | Status: COMPLETED | Results posted: 2025-04-09